Connor, Clark & Lunn Investment Management (CC&L)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,426
| Closed | -$123K | – | 1646 |
|
|
2024
Q1 | $123K | Sell |
26,426
-34,735
| -57% | -$162K | ﹤0.01% | 1452 |
|
|
2023
Q4 | $253K | Sell |
61,161
-25,992
| -30% | -$108K | ﹤0.01% | 1213 |
|
|
2023
Q3 | $261K | Sell |
87,153
-17,362
| -17% | -$52.1K | ﹤0.01% | 1179 |
|
|
2023
Q2 | $257K | Sell |
104,515
-5,444
| -5% | -$13.4K | ﹤0.01% | 1144 |
|
|
2023
Q1 | $249K | Sell |
109,959
-8,692
| -7% | -$19.6K | ﹤0.01% | 1048 |
|
|
2022
Q4 | $414K | Buy |
118,651
+84,315
| +246% | +$294K | ﹤0.01% | 916 |
|
|
2022
Q3 | $1.27M | Buy |
+34,336
| New | +$1.27M | 0.01% | 600 |
|